CDKN2A and head and neck squamous cell carcinoma: In conclusion, the results of the meta-analysis showed aberrant methylation of p16INK4a promoter was found to be associated with HNSCC, which suggested that promoter methylation of p16INK4a may be a potential biomarker in the carcinogenic process of HNSCC.